Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Velaglucerase Alfa in Type 1 Gaucher Disease
NCT00635427Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2008
- Primary completion
- Dec 2012
- Modality
- Replacement Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of velaglucerase alfa in Gaucher disease type 1 (GD1), sponsored by Takeda. Started Mar 2008; status: completed.
02
Drugs
velaglucerase alfa
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT00635427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635427.